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Purpose: To isolate and identify chemical constituents with yeast α-glucosidase inhibitory activity from 
the methanol extract of V. myrtillus (blueberry) flowers.  
Methods: The active fraction (ethyl acetate extract) were chromatographed on C18 MPLC column, 
Sephadex LH-20 column and semi-preparative HPLC column. The isolated compounds were identified 
by the extensive 1H-nuclear magnetic resonance spectroscopy (NMR), 13C-NMR, 2D-NMR and high 
resolution mass spectral (HR-MS) analyses.   
Results: Two phenolic compounds, an acylated flavonoid and a coumaric acid derivative, were isolated 
and identified as isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-glucoside (1) and cis-cinnamic acid methyl 
(2). Compound 1 showed powerful α-glucosidase inhibitory activity and in this regard, was superior to 
the positive drug, acarbose. 
Conclusion: Compounds 1 and 2 were isolated for the first time from this species and the genus of 
Vaccinium. This is the first report on characterization of these phenolic compounds and the possible 
utilization of blueberry flowers for nutraceutical and functional food applications. 
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Postprandial hyperglycemia is recognized as 
characteristic of type 2 diabetes mellitus and 
plays an important role in the development of 
some chronic complications including circulatory 
disease, stroke, hypertension, blindness, kidney 
failure, uremia and gangrene of the lower limbs 
[1]. It is well known that inhibition of carbohydrate 
hydrolysis enzymes linked to diabetes is 
considered an effective approach to treat or 
prevent type 2 diabetes mellitus. Therefore, α-
glucosidase and α-amylase are frequently used 
to screen therapeutic agents derived from the 
natural plants and isolated compounds for control 
of postprandial hyperglycemia [2]. Vaccinium 
corymbosum, also called the northern highbush 
blueberry, is a species of blueberry native to 
eastern North America. It is 
a deciduous shrub growing to 6 – 12 feet tall and 
wide. 
 
There are a great number of interests worldwide 
in blueberry because of its high content of 
beneficial constituents (such as anthocyanins, 
flavonols, tannins, stilbenoids and phenolic 
acids) and potential health benefits. Among 
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those constituents, anthocyanins are considered 
to be one of the dominant blueberry polyphenols. 
It has been reported that blueberry extracts and 
its phytochemicals exhibit antioxidant [3], α-
amylase and α-glucosidase inhibitory activity [4], 
anti-proliferation [5], lipid-lowering activity [6] and 
cardioprotective effect [7].  
 
Recently blueberry fruits extracts have been 
shown to exhibit carbohydrate enzyme inhibitory 
activities but the active compounds were not 
identified [4].  The purpose of this study was to 
isolate and investigate the hypoglycemic activity 
compounds against inhibition of yeast α-






The flowers of high bush blueberry were 
collected from Morgan Farms (North Kingstown, 
RI, USA) in May 2009 and authenticated by Mr J 
Peter Morgan (a senior gardener of University of 
Rhode Island). A voucher specimen (16JPM51-
VCJ51309FL) was deposited in the Heber-
Youngken Garden and Greenhouse at the 
College of Pharmacy, University of Rhode Island 
(Kingston, RI, USA). 
 
Equipment and chemicals  
 
1H and 13C-NMR data were recorded on a Varian 
500 MHz instrument with tetramethylsilane 
(TMS) as internal standard. High solution 
electrospray ionization mass spectral (HR-ESI-
MS) data were acquired on a Q-Star Elite 
(Applied Biosystems MDS, USA) mass 
spectrometer. Medium pressure liquid 
chromatography (MPLC) separations were 
carried out on a C18 column connected to a 
DLC-10/11 isocratic liquid chromatography pump 
(D-Star Instruments, Manassas, VA, USA). High 
performance liquid chromatography (HPLC) was 
performed on a Hitachi Elite LaChrom system 
consisting of a L-2130 pump, L-2200 
autosampler, and a L-2455 diode array detector 
was operated by EZChrom Elite software. All 
solvents, either ACS or HPLC grade, were 
purchased from Wilkem Scientific (Pawtucket, RI, 
USA). α-glucosidase (yeast, EC 3.2.1.20) 
powder and 4-nitrophenyl-α-D-glucopyranoside 
(pNPG) were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). 
 
Extraction and chromatography 
 
The flowers (1.3 kg, fresh weight) were extracted 
exhaustively with MeOH (3 × 4.3 L) at room 
temperature to yield a dried MeOH extract (138 
g). A portion of the extract (133 g) was re-
suspended in H2O (750 mL) and partitioned with 
EtOAc (3 × 750 mL) and n-butanol to yield a 
dried EtOAc extract (33 g) and n-butanol soluble 
fractions, respectively.  
 
Isolation of active compounds 
 
The EtOAc fraction (A) (32 g) was 
chromatographed on a C18 MPLC column (4 × 
37 cm) eluting with a gradient system of 
MeOH/H2O (1:9 to 7:3, v/v) to afford 6 sub-
fractions (A1-A6) which were combined based on 
analytical HPLC analyses. Fraction A1 (18 g) was 
chromatographed over a column of Sephadex 
LH-20 (3.5 × 120 cm) eluted with MeOH to give 5 
sub-fractions (B1 - B5). Fraction B5 was 
chromatographed on a C18 MPLC column (2 × 
15 cm) eluting with a gradient system of 
MeOH/H2O (2:8 to 7:3, v/v) to afford 9 sub-
fractions (C1 - C9). Fraction C8 was separated by 
semi-preparative HPLC eluted with MeOH:H2O 
(61:39, v/v; 3.0 mL/min) to yield compound 1 (1.5 
mg). Fraction A5 was separated by semi-
preparative HPLC eluted with MeOH:H2O (from 
4:6 to 6.5:3.5, v/v, for a period of 25 min, at a 
rate of 3.0 mL/min) to yield compound 2 (1.2 
mg). 
 
Yeast α-Glucosidase inhibitory assay 
 
Yeast α-Glucosidase inhibitory activity was 
determined as described in the literature [10]. 
Briefly, a mixture of 50 μL of different 
concentrations of each of the samples (ethyl 
acetate fraction, n-buthanol fraction or two pure 
compounds) and 100 μL of 0.1 M phosphate 
buffer (pH 6.9) containing yeast α-glucosidase 
solution (1.0 U/ml) was incubated in 96 well 
plates at 25 °C for 10 min. After this pre-
incubation period, 50 μL of 5 mM pNPG solution 
in 0.1 M phosphate buffer (pH 6.9) was added to 
each well at predetermined intervals. The 
reaction mixtures were incubated at 25 °C for 
5 min. Absorbance was recorded at 405 nm 
before and after incubation with a micro-plate 
reader (SpectraMax M2) and compared to that of 
the control which had 50 μL buffer solutions 
instead of test samples. α-Glucosidase inhibitory 
activity, expressed as inhibition (%),was 
calculated as as in Eq 1. 
Inhibition (%) = {(Ac – As)/Ac}100  ------------- (1) 
where Ac is the difference between the 
absorbance values of the control at 5 znd 0 min, 
and As is the difference between the absorbance 
values of the sample at 0 and 5 min. 
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All experiments were performed in triplicate. 
Statistical analysis of data was by Microsoft 
Excel XP and the results were given as mean ± 
standard deviation (SD). p  0.05 was 




Structure elucidation of compounds 1 and 2 
by NMR and HR-ESI-MS analyses 
 
Compound 1 obtained as yellowish amorphous 
powder; UV-vis (MeOH) max = 316, 257 nm; HR-
ESI-MS m/z: 623.0118 [M-H]-(calculated for 
molecular formula C31H27O14), 662.9734[M+K]+; 
1H-NMR (500 MHz, CD3OD) δ: 7.87 (1H, brs, H-
2'), 7.56 (1H, brd, J = 8.5 Hz, H-6'), 6.86 (1H, d, J 
= 8.4 Hz, H-5'), 6.31 (1H, d, J = 2.0 Hz, H-8) , 
6.14 (1H, d, J = 2.0 Hz, H-6), 7.38 (1H, d, J = 
15.9 Hz, H-7'"), 7.31 (2H, brd, J = 8.2 Hz, H-2'", 
6'"), 6.81 (2H, brd, J = 8.2 Hz, H-3'", 5'"), 6.06 
(1H, dd, J = 15.9, 1.2 Hz, H-8"'), 5.35 (1H, d, J = 
7.4 Hz, H-1"), 4.28 (1H, d, J = 11.5 Hz, H-6"a), 
4.20 (1H, dd, J = 11.6, 6.7 Hz, H-6"b), 3.51 – 
3.45 (3H, m, H-2", 3", 4"). 13C-NMR (125 MHz, 
CD3OD) δ: 178.0(C-4), 164.3(C-7), 161.6(C-5), 
157.4(C-2), 157.0(C-9), 149.4(C-4'), 146.8(C-3'), 
134.5(C-3), 122.4(C-6'), 121.3(C-1'), 114.5(C-5'), 
112.8(C-2'), 103.6(C-10), 98.5(C-6), 93.3(C-8), 
167.2(C-9"'), 159.7(C-4"'), 145.1(C-7"'), 129.8(C-
2'", 6"'), 125.5(C-1'"), 115.3(C-3"', 5"'), 113.1(C-
8"'), 102.3(C-1"), 76.5(C-3"), 74.4(C-5"), 74.3(C-
2"), 70.3(C-4"), 62.7(C-6"), 55.2(OCH3). The 
NMR data were consistent with the literature [8]. 
Compound 1 was identified as isorhamnetin-3-O-
(6''-O-coumaroyl)-β-D-glucoside (1). 
 
Compound 2 obtained as yellowish amorphous 
powder; UV-vis (MeOH) max = 309, 228 nm; (+) 
HR-ESI-MS, m/z: 201.0480 [M+Na]+(calcd for 
molecular formula C10H10O3Na). 1H-NMR (500 
MHz, CD3OD) δ: 7.61 (2H, d, J = 8.3 Hz, H-2, 6), 
6.86 (1H, d, J = 12.8 Hz, H-7), 6.75 (2H, d, J = 
8.3 Hz, H-3, 5), 5.77 (1H, d, J = 12.8 Hz, H-8), 
3.70 (3H, s, OCH3). 13C-NMR (125 MHz, CD3OD) 
δ: 167.3(C-9), 158.6(C-4), 143.7(C-7), 132.2 (C-
2, 6), 126.2(C-1), 114.4(C-3, 5), 114.8(C-8), 
50.3(OCH3). The NMR data were consistent with 
the literature [9]. Compound 2 was identified as 












 Isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-glucoside (1)   cis-cinnamic acid methyl (2)  
Figure 1: Chemical structures of the compounds (1 
and 2) isolated from blueberry flowers. 
Two phenolic compounds were isolated from the 
ethyl acetate fraction and identified by the NMR 
and HR-ESI-MS analyses. The 1H-NMR 
spectrum of compound 1 exhibited typical signals 
for an isorhamnetin moiety [δ: 7.87(1H, brs, H-
2'), 7.56(1H, brd, J = 8.5 Hz, H-6'), 6.86(1H, d, J 
= 8.4 Hz, H-5'), 6.31 (1H, d, J = 2.0 Hz, H-8) , 
6.14 (1H, d, J = 2.0 Hz, H-6)] and a trans-
coumaroyl moiety [δ: 7.38 (1H, d, J = 15.9 Hz, H-
7'"), 7.31 (2H, brd, J = 8.2 Hz, H-2'", 6'"), 
6.81(2H, brd, J = 8.2 Hz, H-3'", 5'"), 6.06 (1H, dd, 
J = 15.9, 1.2 Hz, H-8"')] and signals for an 
anomeric proton of a sugar at δ: 5.35 (1H, d, J = 
7.4 Hz, H-1"). The coupling constant of J = 7.4 
Hz indicated a β-configuration for the glucose 
moiety. The trans-coumaroyl moiety was 
attached to the C-6 of the glucose moiety for the 
H-6" proton signals of the glucose moiety was 
shifted downfield at δ: 4.28 (1H, d, J = 11.8 Hz) 
and 4.20 (1H, dd, J = 11.6, 6.7 Hz), respectively. 
It was further confirmed by the HMBC spectrum, 
which showed the correlations between H-6" 
proton and the ester carbonyl (C-7'"). The 
structure of compound 1 was confirmed as 
isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-Gluco- 
side by comparison with published NMR data [8]. 
1H-NMR and 13C-NMR spectrum of compound 2 
exhibited similar signals to the coumaroyl moiety 
mentioned above. The coupling constant of J = 
12.8 Hz indicated a cis-configuration. The 
structure of compound 2 was confirmed as cis-
cinnamic acid methyl by comparison with 
published NMR data [9]. 
 
The extracts of blueberry flowers showed good 
α-glucosidase inhibitory activity and hence, two 
phenolic compounds (Figures 1 and 2) were 
isolated from the ethyl acetate extract. Also 
isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-gluco-
side (1) was identified as an active constituent in 
the ethyl acetate extract of blueberry flowers. 
 
α-Glucosidase inhibitory activity 
 
Table 1 shows the α-glucosidase inhibitory 
activity of the crude extracts and two isolated 
compounds from blueberry flowers. The ethyl 
acetate and n-buthanol soluble fractions showed 
promising α-glucosidase inhibitory activity 
compared with the positive control drug, 
acarbose. The IC50 values of ethyl acetate and n-
buthanol fractions, and acarbose were 132.7 
μg/mL, 32.3 μg/mL and 129.6 μg/mL (or 200.7 
μM), respectively. Although the n-buthanol 
fraction showed better activity than ethyl acetate 
fraction, HPLC chromatography (data not shown) 
showed that the ethyl acetate extract exhibited 
more detectable peaks. Therefore, further 
isolation was conducted on the ethyl acetate 
fraction.  
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The α-glucosidase inhibitory activity of the two 
isolated compounds was tested at the original 
concentration of 2 mg/mL. Compound 1 
showed > 50 % inhibition activity (p  0.05), while 
compound 2 showed < 50 % ( p > 0.05). Hence, 
compound 1 was further tested and the IC50 was 
calculated (Table 1). 
 
Table 1: Yeast α-glucosidase inhibitory activity (mean 
± SD, n = 3) of crude extracts and isolated compounds 

























 a 200.7 ± 19.7B  
 
a Positive control; b Crude extract IC50 values are expressed 
as μg/mL; c IC50 values of isolated pure compounds 
expressed as μM; data shown as mean ± SD (n = 3); different 
letters within the same column indicate significant difference 




Compound 1 showed better yeast α-glucosidase 
inhibitory activity than the positive drug acarbose 
(Table 1), which was in agreement with previous 
reports that many flavonoids from plants have 
been reported as α-glucosidase inhibitors [11]. 
The present study also suggests that 
coumaroylated moiety could increase the activity 
of the flavonoid glycosides, which was in agree-
ment with those concluded from the studies of 
acylated anthocyanins and flavonol monorham-





side (1) is a promising α-glucosidase inhibitor. 
Therefore, blueberry flower is potentially a good 
source of α-glucosidase inhibitors for 
hyperglycemic therapy. Further studies are 
needed to continue to isolate other the chemical 
constituents of the active fractions and to 
determine the α-glucosidase inhibitory 
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